Anti-BG8 Lewis Y Monoclonal Antibody
IHC517-100
Regular price
$115.00
You Pay
Supplier: GenomeMe
Description:
BG8 LewisY, also known as LewisY blood antigen or simply BG8, is a blood group antigen that has been identified in many studies as a potential marker for differentiation between pulmonary adenocarcinoma (PACA) and epithelioid mesothelioma (EM). It has been reported that sensitivity of non-mesothelial antigens for adenocarcinoma is organ-dependent. When attempting to differentiate epithelioid mesothelioma from adenocarcinoma, BG8 LewisY performed at a sensitivity of 98% in the breast cancer group, and 100% in the lung cancer group.
Clone | IHC517 |
Source |
Mouse Monoclonal |
Positive Control | Lung Adenocarcinoma |
Dilution Range | 1:100 - 1:400 |
Figure: GeneAbTM BG8, Lewisy [IHC517] on Thyroid Cancer
References
- Sheibani K, et al. Am J Surg Pathol. 1991; 15:779-84.
- Marchevsky AM, et al. Appl Immunohistochem Mol Morphol. 2007; 15:140-4.
- Davidson B, et al. Virchows Arch. 1999; 435:43-9.
- Ordonez NG. Am J Surg Pathol. 2003; 27:1031-51.
- Ordonez NG. Am J Surg Pathol. 2000; 24: 598-606.
- Ordonez NG. Am J Clin Pathol. 1998; 109:85-9.
- King JE, et al. Histopathology. 2006; 48:223-32.
- Kao SC, et al. Pathology. 2011; 43:313-7.
- Yaziji H, et al. Mod Pathol. 2006; 19:514-23.